Covered recipient · General Payments record
TEDDI L DOWLING
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,017.87
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $283.42 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $54.74 | 3 |
| Merck Sharp & Dohme Corporation | $24.52 | 1 |
| BeiGene USA, Inc. | $23.48 | 1 |
| Lilly USA, LLC | $21.05 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.87 | 1 |
| Celgene Corporation | $20.03 | 1 |
| ARRAY BIOPHARMA INC | $18.40 | 1 |
| Axonics Modulation Technologies, Inc. | $17.71 | 1 |
| Astellas Pharma US Inc | $17.62 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.35 | 1 |
| Janssen Biotech, Inc. | $17.05 | 1 |
| Daiichi Sankyo Inc. | $15.56 | 1 |
| JAZZ PHARMACEUTICALS INC. | $15.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC | $18.40 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131197315 | CMS |
| Astellas Pharma US Inc | $17.62 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139526368 | CMS |
| Axonics, Inc. | $17.71 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142391863 | CMS |
| BeiGene USA, Inc. | $23.48 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120862917 | CMS |
| Celgene Corporation | $20.03 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101182420 | CMS |
| Daiichi Sankyo Inc. | $15.56 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089416906 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.87 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101756840 | CMS |
| Janssen Biotech, Inc. | $17.05 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078645653 | CMS |
| JAZZ PHARMACEUTICALS INC. | $15.04 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151305112 | CMS |
| Lilly USA, LLC | $21.05 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135979020 | CMS |
| Merck Sharp & Dohme LLC | $24.52 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141646564 | CMS |
| Novartis Pharmaceuticals Corporation | $17.35 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086828315 | CMS |
| PFIZER INC. | $19.64 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131197311 | CMS |
| PFIZER INC. | $16.62 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131343794 | CMS |
| PFIZER INC. | $18.48 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131393602 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.